Viewing Study NCT04018833

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-23 @ 2:50 PM
Study NCT ID: NCT04018833
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2019-07-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema
Sponsor: Bernardete Pessoa MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
None Diabetic Retinopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic Macular Edema View
None Bevacizumab View
None Ranibizumab View
None Aflibercept View
None BCVA View
None OCT View